Market Tracker

09/01 1:05pm ET

Novavax Inc (NASDAQ:NVAX)

4.69
Data as of Aug 29
 +0.07 / +1.52%
Today’s Change
2.68
Today|||52-Week Range
6.95
-8.40%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close4.62
Today’s open4.62
Day’s range4.56 - 4.71
Volume1,463,895
Average volume (3 months)3,770,332
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+10.27%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.82

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+3.03+8.19%
KITEKite Pharma Inc+0.96+3.52%
HALOHalozyme Therapeutic...+0.04+0.42%
IMGNImmunoGen Inc+0.16+1.37%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts